Neal Mahutte
Overview
Explore the profile of Neal Mahutte including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
173
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sierra S, Min J, Saumet J, Shapiro H, Sylvestre C, Roberts J, et al.
Reprod Biomed Online
. 2025 Feb;
50(3):104456.
PMID: 40015079
This guideline defines recurrent early pregnancy loss (REPL) as two or more losses that occur before 10 weeks gestational age and includes non-consecutive and biochemical losses. Investigations should be considered...
2.
Peero E, Banjar S, Khoudja R, Ton-Leclerc S, Beauchamp C, Benoit J, et al.
Sci Rep
. 2024 Feb;
14(1):3876.
PMID: 38365988
The effectiveness of intravenous immunoglobulin (IVIg) for patients with unexplained recurrent implantation failure (uRIF) remains debated. We retrospectively analysed outcomes of uRIF patients treated with IVIg compared to a separate...
3.
Banjar S, Kadour E, Khoudja R, Ton-Leclerc S, Beauchamp C, Beltempo M, et al.
Am J Reprod Immunol
. 2023 Jul;
90(2):e13737.
PMID: 37491929
Problem: Recurrent pregnancy loss (RPL) affects up to 4% of couples attempting to conceive. RPL is unexplained in over 50% of cases and no effective treatments exist. Due to the...
4.
Genest G, Banjar S, Almasri W, Beauchamp C, Benoit J, Buckett W, et al.
Reproduction
. 2022 Nov;
165(2):R39-R60.
PMID: 36322478
In Brief: Immune dysfunction may contribute to or cause recurrent implantation failure. This article summarizes normal and pathologic immune responses at implantation and critically appraises currently used immunomodulatory therapies. Abstract:...
5.
Mahutte N, Meng L, Lanes A, Liu K
Fertil Steril
. 2022 Jun;
118(2):429.
PMID: 35725673
No abstract available.
6.
Miner S, Gelgoot E, Lahuec A, Wunderlich S, Safo D, Brochu F, et al.
Digit Health
. 2022 Jun;
8:20552076221102248.
PMID: 35646384
Objective: The number of couples experiencing infertility treatment has increased, as has the number of women and men experiencing infertility treatment-related stress and anxiety. Therefore, there is a need to...
7.
Mahutte N, Hartman M, Meng L, Lanes A, Luo Z, Liu K
Fertil Steril
. 2022 Feb;
117(4):792-800.
PMID: 35109980
Objective: To study the effect of increasing endometrial thickness on live birth rates in fresh and frozen-thaw embryo transfer (FET) cycles. Design: Retrospective cohort study. Setting: National data from Autologous...
8.
Noah Gelgoot E, Kelly-Hedrick M, Miner S, Robins S, Chan P, Ells C, et al.
Patient Educ Couns
. 2020 Apr;
103(9):1812-1820.
PMID: 32273146
Objective: To examine if and how factors associated with infertility-related concerns and opportunity to discuss concerns differ between male and female fertility patients. Methods: A cross-sectional survey of 313 female...
9.
Brochu F, Robins S, Miner S, Grunberg P, Chan P, Lo K, et al.
J Med Internet Res
. 2019 Dec;
21(12):e15132.
PMID: 31829963
Background: Given the complexity of infertility diagnoses and treatments and the convenience of the internet for finding health-related information, people undergoing infertility treatments often use Web-based resources to obtain infertility...
10.
Fortin C, Leader A, Mahutte N, Hamilton S, Leveille M, Villeneuve M, et al.
J Assist Reprod Genet
. 2019 Apr;
36(6):1195-1210.
PMID: 31001707
Purpose: Hormonal stimulation prior to IVF influences the ovarian environment and therefore impacts oocytes and subsequent embryo quality. Not every patient has the same response to the same treatment and...